$24.99−0.27 (−1.07%)
At close: Nov 17, 2026, 4:00 PM ET· Nasdaq · USD
Privia Health Group (PRVA) Income Statement
Is this a real, growing, cash-generative business, or a story propped up by accounting?
Sources Company filings FilingsHow we compute thisNot investment advice
13 figures withheld by our checks. Each blank figure names its reason.
Business engineGrowing fast: revenue compounds ~21.7%/yr (FY21→FY25), net margin 1.1%. Worth your attention in FY25: Share count (+25.2%). Visible in the receipts below.
The four lines that matter · FY21–FY25
Revenue ($M)▲22.3%
2,122.8
FY21→FY25CAGR +21.7%/yr
Net income ($M)▲59.3%
22.9
one-off year: see footnoteCAGR —
Free cash flow ($M)—
—
no FY25 valueCAGR —
Diluted EPS▲63.6%
0.18
FY21→FY25CAGR —
What the receipts whisper · what a headline number hides
Share count
+25.2%
103.0mn → 128.9mn diluted shares since FY21. Rising share count dilutes EPS. Growth must outrun it.
What the income statement says · FY21–FY25
Where every revenue dollar goes · FY25 ($M)
1¢ of every revenue dollar becomes profit. The biggest cost lever is operating expenses.
Margin trend · direction beats level Gross Operating Net
Over this window: gross 81.9% → 88.1%. Net margin 1.1% is below the sector median.
The receipt · income statement · FY21–FY25 USD thousands except per-share & ratios · hover a line for its definition
USD thousands except per-share & ratios
| Line item | TTM † | FY25 | FY24 | FY23 | FY22 | FY21 | YoY | CAGR 21→25 |
|---|---|---|---|---|---|---|---|---|
| Revenue & profitability | ||||||||
Revenue | 2,434,610.0 | 2,122,842.0 | 1,736,390.0 | 1,657,737.0 | 1,356,660.0 | 966,220.0 | ▲22.3% | +21.7% |
Cost of revenue | 274,291.0 | 252,732.0 | 227,000.0 | 197,663.0 | 170,838.0 | 174,731.0 | ▲11.3% | +9.7% |
Gross profit | 2,160,319.0 | 1,870,110.0 | 1,509,390.0 | 1,460,074.0 | 1,185,822.0 | 791,489.0 | ▲23.9% | +24.0% |
Selling, general & admin | 144,854.0 | 138,152.0 | 126,157.0 | 109,587.0 | 129,592.0 | 255,884.0 | ▲9.5% | −14.3% |
Total operating expenses | 2,109,305.0 | 1,835,875.0 | 1,492,408.0 | 1,439,425.0 | 1,204,944.0 | 1,008,925.0 | ▲23.0% | +16.1% |
Operating incomefeeds ROC rank | 51,014.0 | 34,235.0 | 16,982.0 | 20,649.0 | −19,122.0 | −217,436.0 | ▲101.6% | — |
Other income, net | 10,683.0 | 9,703.0 | 10,888.0 | 8,372.0 | 542.0 | −1,070.0 | — | — |
Pretax income | 61,697.0 | 43,938.0 | 27,870.0 | 29,021.0 | −18,580.0 | −218,506.0 | ▲57.7% | — |
Income tax | 23,074.0 | 14,212.0 | 10,826.0 | 7,993.0 | −6,516.0 | −27,857.0 | ▲31.3% | — |
Net incomePiotroski ROA ✓feeds Buffett Quality owner earnings | 34,750.0 | 22,919.0 | 14,385.0 | 23,079.0 | −8,585.0 | −190,649.0 | ▲59.3% | — |
| Per share | ||||||||
Diluted EPSbuyback-sensitive | 0.27 | 0.18 | 0.11 | 0.19 | −0.08 | −1.83 | ▲63.6% | — |
Diluted shares (mn) | 132.71 | 128.89 | 125.61 | 124.69 | 110.70 | 102.95 | ▲2.6% | +5.8% |
| Margins | ||||||||
Gross margin83rd pct in Healthcare | 88.7% | 88.1% | 86.9% | 88.1% | 87.4% | 81.9% | ▲1.2pp | +6.2pp |
Operating margin | 2.1% | 1.6% | 1.0% | 1.2% | −1.4% | −22.5% | ▲0.6pp | +24.1pp |
Net margin44th pct in Healthcare | 1.4% | 1.1% | 0.8% | 1.4% | −0.6% | −19.7% | ▲0.3pp | +20.8pp |
† TTM = trailing four quarters through 2026-09-30.FY21 effective tax rate was 13% vs a 32% norm for this window, likely a one-time item; see the filing.
2 more years of statements and CSV export are on Premium.Premium · $119/yr · 7-day trial · cancel anytimeUnlock with Premium →
These lines feed the tenet checklists: see which gates passTenets →Margins & returns continue as sector-ranked ratiosStatistics →
Annual report filed 2026-02-27 · view filings on SEC EDGAR ↗ · reported currency USD · as-filed figures may be later restated.
Statements normalized in our fundamentals DB · Not investment advice.
Statements normalized in our fundamentals DB · Not investment advice.
Common questions
What was Privia Health Group's revenue last fiscal year?
Privia Health Group reported revenue of $2,122.8M in fiscal 2025, up 22.3% from fiscal 2024.
What was Privia Health Group's net income?
Privia Health Group reported net income of $22.9M in fiscal 2025, a net margin of 1.1%.
Annual and quarterly statements as filed, normalized into one comparable shape · Not investment advice.

